Orexo AB revenue for the last year amounted to 63.05 M USD, the most of which — 57.02 M USD — came from its highest performing source at the moment, US Pharma, the year earlier bringing 54.57 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Orexo AB 57.24 M USD, and the year before that — 54.84 M USD.